Differences in substance-related risk behavior between dual and triple diagnosed severely mentally ill adults.

Mental Health and Substance Use : Dual Diagnosis
Michelle Decoux HamptonCarmen Portillo

Abstract

OBJECTIVES: The purpose of this study was to determine if differences exist between adults with dual and triple diagnoses with regard to substance-related risk behaviors. METHODS: This secondary analysis was a cross-sectional study. There were 252 subjects with dual and triple diagnoses recruited from residential crisis programs in San Francisco. Using descriptive and logistic regression analyses, subjects in the two groups were compared with regard to demographic data, types of substances, and routes of administration used in the previous 30 days to determine risk for exposure and/or transmission of HIV/HCV. RESULTS: When compared to the dual diagnosis group, subjects with triple diagnoses were four times more likely to have engaged in IDU (p=.001) and 2.6 times more likely to use amphetamines (p=.05). They also reported using more types of substances over the lifetime (p<.0001). But with regard to other risk behaviors such as alcohol use to intoxication and cocaine/crack use, there were no significant differences. CONCLUSION: Though many substance-related risk behaviors occurred in both groups, adults with triple diagnoses were more likely to engage in IDU, amphetamine use, and to use more types of substances over the life...Continue Reading

References

Oct 21, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·K McKinnon, F Cournos
Jul 18, 2000·AIDS Patient Care and STDs·F B Tate, D A Longo
May 23, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·P Y CollinsE S Susser
Jul 10, 2001·American Journal of Public Health·P S Rosenberg
Aug 18, 2001·Mental Health Services Research·S D PinkertonR G Hoffmann
May 30, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Fred C OsherUNKNOWN Five-Site Health and Risk Study Research Committee
Apr 6, 2004·Substance Use & Misuse·Stephanie TortuRahul Hamid
Nov 24, 2004·Biological Psychiatry·Frances R Levin, Grace Hennessy
Jun 25, 2005·Community Mental Health Journal·Linda ChafetzJohn Nickens
May 17, 2006·Annals of Internal Medicine·Gregory L ArmstrongMiriam J Alter
Dec 5, 2006·Community Mental Health Journal·Christina S Meade, Kathleen J Sikkema
Feb 15, 2007·Journal of Prevention & Intervention in the Community·Kathleen J SikkemaDavid L Snow
Aug 11, 2007·The International Journal on Drug Policy·Pat O'Hare
Nov 9, 2007·American Journal of Respiratory and Critical Care Medicine·Diane E BennettKenneth G Castro
Jun 17, 2008·The Journal of Nervous and Mental Disease·Linda ChafetzJohn Nickens
Sep 19, 2008·American Journal of Public Health·Mary Jane Rotheram-BorusUNKNOWN Healthy Living Trial Group
Nov 13, 2008·Community Mental Health Journal·Michelle DeCoux HamptonLinda Chafetz

❮ Previous
Next ❯

Citations

Sep 22, 2017·Issues in Mental Health Nursing·Linda Chafetz, Gerri Collins-Bride

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.